On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Risk of Transfusion-Transmitted Babesiosis” guidance document with a maximum 12 month implementation timeline. Per the FDA guidance document recommendations, CTS is developing a specific implementation plan for mandatory Babesia testing well before the May 8, 2020 deadline.
Check out the Communication page for the complete details by clicking the link: Communications
The Q & A document from the Reentry Changes Webinar hosted on 06/06/18 has been posted in the Wh...
National Blood Donor Month has been observed in January since 1970, with the goal of increasing bloo...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for sample...
The CTS Medical Advisory Board recently agreed upon a revision to our standard testing algorithm. Th...
Reminder - The CTS Reentry form, CTS-00172, will be updated on Monday July 2, 2018. It's posted ...